Indexed in Journament

clinical pharmacology and therapeutics

ISSN 1532-6535· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
43.6/100
Journament Score
#643
Journament Rank
11
Articles Indexed

About This Journal

Short Name clin pharmacol ther
Abbreviated Name clin pharmacol ther
ISSN 1532-6535
URL http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535

Indexings

ncbi

Tools & Certificate of Indexing

Certificate of Indexing
Quality Badge Widget - Embed on Your Website

Display your journal's verified indexing scores on your website with our self-contained widget.

One-Line JavaScript Embed:
Advantages: Single-line script, seamless DOM integration, clickable badges linking to full journal profile.
Standard iFrame Embed Code:
Widget Preview:

Publications Per Year

Articles (11)

2020
Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.
Conrado, Daniela J;Duvvuri, Sridhar;Geerts, Hugo;Burton, Jackson;Biesdorf, Carla;Ahamadi, Malidi;Macha, Sreeraj;Hather, Gregory;Morales, Juan Francisco;Podichetty, Jagdeep;Nicholas, Timothy;Stephenson, Diane;Trame, Mirjam;Romero, Klaus;Corrigan, Brian;, ;
430 views DOI Abstract
2020
Development of a System for Post-marketing Population Pharmacokinetic and Pharmacodynamic Studies using Real-World Data from Electronic Health Records.
Choi, Leena;Beck, Cole;McNeer, Elizabeth;Weeks, Hannah L;Williams, Michael L;James, Nathan T;Niu, Xinnan;Abou-Khalil, Bassel W;Birdwell, Kelly A;Roden, Dan M;Stein, C Michael;Bejan, Cosmin A;Denny, Joshua C;Van Driest, Sara L;
422 views DOI Abstract
2020
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.
Damle, Bharat;Vourvahis, Manoli;Wang, Erjian;Leaney, Joanne;Corrigan, Brian;
402 views DOI Abstract
2002
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund, Werner;Ludwig, Karen;Giessmann, Thomas;Dazert, Peter;Schroeder, Eike;Sperker, Bernhard;Warzok, Rolf;Kroemer, Heyo K;Cascorbi, Ingolf;
Vol. 72 , No. 5 , pp. 572-83
400 views Abstract
2020
MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges.
Krishnaswami, Sriram;Austin, Daren;Della Pasqua, Oscar;Gastonguay, Marc R;Gobburu, Jogarao;van der Graaf, Piet H;Ouellet, Daniele;Tannenbaum, Stacey;Visser, Sandra A G;
382 views DOI Abstract
2019
Model-informed dose selection for Xentuzumab, a dual insulin-like growth factor-I/II -neutralizing antibody.
Parra-Guillen, Zinnia P;Schmid, Ulrike;Janda, Alvaro;Freiwald, Matthias;Troconiz, Iñaki F;
364 views DOI Abstract
2019
Can Insights From Placebo and Nocebo Mechanism Studies Help Improve Randomized Controlled Trials?
Vase, Lene;
321 views DOI
2002
Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition.
Siegmund, Werner;Altmannsberger, Stephan;Paneitz, Andrea;Hecker, Ute;Zschiesche, Michael;Franke, Gerd;Meng, Wieland;Warzok, Rolf;Schroeder, Eike;Sperker, Bernhard;Terhaag, Bernd;Cascorbi, Ingolf;Kroemer, Heyo K;
Vol. 72 , No. 3 , pp. 256-64
311 views Abstract
2020
Target adverse event profiles for predictive safety in the post-market setting.
Schotland, Peter;Racz, Rebecca;Jackson, David B;Soldatos, Theodoros G;Levin, Robert;Strauss, David;Burkhart, Keith;
281 views DOI Abstract
2020
Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2
Thakur A;Tan SPF;Chan JCY;;
, pp. -
277 views Abstract
2020
Target adverse event profiles for predictive safety in the post-market setting.
Schotland, Peter;Racz, Rebecca;Jackson, David B;Soldatos, Theodoros G;Levin, Robert;Strauss, David;Burkhart, Keith;
281 views DOI Abstract
2020
Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2
Thakur A;Tan SPF;Chan JCY;;
, pp. -
277 views Abstract
2020
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.
Damle, Bharat;Vourvahis, Manoli;Wang, Erjian;Leaney, Joanne;Corrigan, Brian;
402 views DOI Abstract
2020
Development of a System for Post-marketing Population Pharmacokinetic and Pharmacodynamic Studies using Real-World Data from Electronic Health Records.
Choi, Leena;Beck, Cole;McNeer, Elizabeth;Weeks, Hannah L;Williams, Michael L;James, Nathan T;Niu, Xinnan;Abou-Khalil, Bassel W;Birdwell, Kelly A;Roden, Dan M;Stein, C Michael;Bejan, Cosmin A;Denny, Joshua C;Van Driest, Sara L;
422 views DOI Abstract
2020
Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.
Conrado, Daniela J;Duvvuri, Sridhar;Geerts, Hugo;Burton, Jackson;Biesdorf, Carla;Ahamadi, Malidi;Macha, Sreeraj;Hather, Gregory;Morales, Juan Francisco;Podichetty, Jagdeep;Nicholas, Timothy;Stephenson, Diane;Trame, Mirjam;Romero, Klaus;Corrigan, Brian;, ;
430 views DOI Abstract
2020
MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges.
Krishnaswami, Sriram;Austin, Daren;Della Pasqua, Oscar;Gastonguay, Marc R;Gobburu, Jogarao;van der Graaf, Piet H;Ouellet, Daniele;Tannenbaum, Stacey;Visser, Sandra A G;
382 views DOI Abstract
2019
Model-informed dose selection for Xentuzumab, a dual insulin-like growth factor-I/II -neutralizing antibody.
Parra-Guillen, Zinnia P;Schmid, Ulrike;Janda, Alvaro;Freiwald, Matthias;Troconiz, Iñaki F;
364 views DOI Abstract
2019
Can Insights From Placebo and Nocebo Mechanism Studies Help Improve Randomized Controlled Trials?
Vase, Lene;
321 views DOI
2002
Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition.
Siegmund, Werner;Altmannsberger, Stephan;Paneitz, Andrea;Hecker, Ute;Zschiesche, Michael;Franke, Gerd;Meng, Wieland;Warzok, Rolf;Schroeder, Eike;Sperker, Bernhard;Terhaag, Bernd;Cascorbi, Ingolf;Kroemer, Heyo K;
Vol. 72 , No. 3 , pp. 256-64
311 views Abstract
2002
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund, Werner;Ludwig, Karen;Giessmann, Thomas;Dazert, Peter;Schroeder, Eike;Sperker, Bernhard;Warzok, Rolf;Kroemer, Heyo K;Cascorbi, Ingolf;
Vol. 72 , No. 5 , pp. 572-83
400 views Abstract
44
Overall
Below Average
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

43.6/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.9/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

35.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.